Exact Sciences Corporation (EXAS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
18.57+0.89 (+5.03%)
At close: 4:00 PM EDT
People also watch:
EXELACADCLDXARRYSRPT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open17.79
Prev Close17.68
Bid17.50 x 100
Ask18.70 x 100
Day's Range17.69 - 18.70
52wk Range4.67 - 22.80
1y Target EstN/A
Market Cap2.01B
P/E Ratio (ttm)-10.23
Beta0.57
Volume2,514,664
Avg Vol (3m)4,071,898
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : September 30, 2016
    Capital Cubeyesterday

    EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : September 30, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for EXACT Sciences Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Capital Cube2 days ago

    ETF’s with exposure to EXACT Sciences Corp. : September 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to EXACT Sciences Corp. Here are 5 ETF’s with the largest exposure to EXAS-US. Comparing the performance and risk of EXACT Sciences Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PR Newswire3 days ago

    Exact Sciences to host third-quarter 2016 results webcast and call

    Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the guidelines of the U.S. Multi-Society Task Force on Colorectal Cancer.